Biolase Technology conducts inter partes reexamination of U.S. Patent No. 7,485,116
Client(s) Biolase Technology Inc.
Jones Day represents Biolase Technology Inc. in an inter partes reexamination of U.S. Patent No. 7,485,116.
Client(s) Biolase Technology Inc.
Jones Day represents Biolase Technology Inc. in an inter partes reexamination of U.S. Patent No. 7,485,116.